JPH10152424A - Composition for oral cavity - Google Patents

Composition for oral cavity

Info

Publication number
JPH10152424A
JPH10152424A JP31204996A JP31204996A JPH10152424A JP H10152424 A JPH10152424 A JP H10152424A JP 31204996 A JP31204996 A JP 31204996A JP 31204996 A JP31204996 A JP 31204996A JP H10152424 A JPH10152424 A JP H10152424A
Authority
JP
Japan
Prior art keywords
composition
common salt
granular
salt
grain diameter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP31204996A
Other languages
Japanese (ja)
Other versions
JP3667472B2 (en
Inventor
Yoshiyuki Muroi
愛行 室井
Kazushi Oshino
一志 押野
Hiroki Kamiyama
弘樹 上山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP31204996A priority Critical patent/JP3667472B2/en
Publication of JPH10152424A publication Critical patent/JPH10152424A/en
Application granted granted Critical
Publication of JP3667472B2 publication Critical patent/JP3667472B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject composition, capable of raising the blood flow rate by excellent massaging effects and excellent in preventing and therapeutic effects on periodontosis by including a granular common salt having a specific average grain diameter in a specific proportion therein. SOLUTION: This composition is obtained by formulating (A) 3-15wt.% granular common salt having 700-1,400μm, preferably 800-1,200μm average grain diameter with, as necessary, (B) 5-30wt.% sodium bicarbonate having 30-500μm average particle diameter, granular common salt having the grain diameter other than that in the ingredient A, 15-40wt.% common salt in the form other than that in the ingredient A such as a solutionlike common salt, a humectant, a binder, a dentine reinforcing agent, a germicide, enzymes, an antiinflammatory agent, a blood circulation promoter, a surfactant, a sweetener, a colorant, coloring matters, a perfume, etc. The resultant composition can be used as, e.g. a toothpaste, a tooth powder or a gingival local liniment.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、優れたマッサージ
効果により、血流量を高めることができ、歯周疾患の予
防・治療効果に優れた口腔用組成物に関する。
TECHNICAL FIELD The present invention relates to an oral composition which can enhance blood flow by an excellent massage effect and is excellent in the effect of preventing and treating periodontal disease.

【0002】[0002]

【従来の技術】歯周疾患は、う蝕と並んで口腔領域にお
ける二大疾患の1つである。特に、歯槽膿漏は、今日の
ような高齢化社会においては深刻な問題となっている。
従って、その予防・治療は口腔衛生上、非常に重要な意
味を持っており、それらを目的とした食塩を薬効剤とし
た練歯磨が市販されている。この食塩の作用は炎症を起
こした歯肉中の組織液を吸収することにより、歯肉局所
における循環が改善される為といわれている。しかし、
この食塩の効果を高める目的で、高濃度の食塩を配合す
ると、塩辛さが強くなり、口腔用組成物としての嗜好性
が著しく損なわれるという欠点があった。そこで、口腔
用組成物中に粒径の大きな溶解していない粒状食塩を配
合することにより、塩辛さを低減することが行われてい
る(特公平3-2122号公報)。従来、塩辛さを低減するた
めには、平均粒径300〜500μm程度の粒状食塩が使用さ
れている。
2. Description of the Related Art Periodontal disease is one of the two major diseases in the oral region along with caries. In particular, alveolar pyorrhea is a serious problem in today's aging society.
Therefore, its prevention and treatment have a very important meaning in oral hygiene, and toothpastes using salt as a medicinal agent for these purposes are commercially available. It is said that the action of this salt is to improve tissue circulation in local gingiva by absorbing tissue fluid in inflamed gingiva. But,
When a high concentration of sodium chloride is added for the purpose of enhancing the effect of the salt, there is a disadvantage that the saltiness becomes strong and the palatability as an oral composition is significantly impaired. Therefore, saltiness is reduced by blending an undissolved granular salt having a large particle diameter into the oral composition (Japanese Patent Publication No. 3-2122). Conventionally, granular salt having an average particle size of about 300 to 500 μm has been used to reduce saltiness.

【0003】しかしながら、このような粒状食塩を含有
する口腔用組成物では、食塩による薬効剤としての効果
は得られるものの、十分な血流促進効果は得られなかっ
た。
[0003] However, in the oral composition containing such a granular salt, although the effect of the salt as a medicinal agent can be obtained, a sufficient blood flow promoting effect cannot be obtained.

【0004】[0004]

【発明が解決しようとする課題】従って、本発明の目的
は、高い血流促進効果が得られ、歯周疾患の予防・治療
効果に優れた口腔用組成物を提供することにある。
SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide an oral composition which has a high blood flow promoting effect and is excellent in the prevention and treatment of periodontal disease.

【0005】[0005]

【課題を解決するための手段】かかる実情において、本
発明者らは鋭意研究を行った結果、特定粒径の粒状食塩
を用いれば、優れたマッサージ効果により血流量を高め
ることができ、歯周疾患の予防・治療効果に優れた口腔
用組成物が得られることを見出し、本発明を完成した。
Under such circumstances, the present inventors have conducted intensive studies and as a result, it has been found that the use of granular salt having a specific particle size can increase the blood flow rate due to an excellent massage effect, and to increase the periodontal periodontal. The present inventors have found that an oral composition excellent in the effects of preventing and treating diseases can be obtained, and have completed the present invention.

【0006】すなわち、本発明は、組成物中において、
平均粒径が700〜1400μmの粒状食塩を3〜15重量%含有
する口腔用組成物を提供するものである。
That is, the present invention provides a composition comprising:
It is intended to provide an oral composition containing 3 to 15% by weight of granular salt having an average particle size of 700 to 1400 µm.

【0007】[0007]

【発明の実施の形態】本発明で用いられる粒状食塩は、
組成物中での平均粒径が700〜1400μm、好ましくは700
〜1200μm、特に好ましくは800〜1200μmのものであ
る。平均粒径が700μm未満のものでは粒子径が小さいた
め、十分なマッサージ効果が得られず、1400μmを超え
るものでは単位重量当りの粒子数が減少し、歯肉との接
触回数が少なくなるため、十分なマッサージ効果が得ら
れない。
DETAILED DESCRIPTION OF THE INVENTION The granular salt used in the present invention is:
The average particle size in the composition is 700 to 1400 μm, preferably 700
12001200 μm, particularly preferably 800-1200 μm. If the average particle diameter is less than 700 μm, the particle diameter is small, so that a sufficient massage effect cannot be obtained.If the average particle diameter is more than 1,400 μm, the number of particles per unit weight decreases, and the number of times of contact with the gingiva decreases. A good massage effect cannot be obtained.

【0008】このような粒状食塩は、平均粒径が上記範
囲であればよいが、700μm以上の粒子が全体の30%以
上、特に40%以上であるものが好ましい。更に、平均粒
径が750〜900μmの粒子が全体の50%以上、特に70%以
上であると、口中での感触の点でより好ましい。
[0008] Such a granular salt may have an average particle diameter in the above-mentioned range, but it is preferable that particles having a diameter of 700 µm or more account for 30% or more, particularly 40% or more of the whole. Further, it is more preferable that particles having an average particle diameter of 750 to 900 μm be 50% or more, particularly 70% or more of the whole in terms of feeling in the mouth.

【0009】本発明において、粒状食塩は組成物中に3
〜15重量%含有され、好ましくは3〜12重量%、特に好
ましくは5〜10重量%含有される。3重量%未満では十
分なマッサージ効果が得られず、15重量%を超えると、
使用時の感触及び味がひどく劣る。なお、粒状食塩は製
造中に溶解して粒径が小さくなったり、前記粒径の食塩
の含有量が減少したりするため、製造後に得られた組成
物中での平均粒径及び含有量が前記のような範囲になる
よう、予め組成物中での所望の量より多い配合量の粒状
食塩を用いて製造するのが好ましい。
In the present invention, granular salt is contained in the composition at 3%.
-15% by weight, preferably 3-12% by weight, particularly preferably 5-10% by weight. If it is less than 3% by weight, a sufficient massage effect cannot be obtained, and if it exceeds 15% by weight,
The feel and taste during use are very poor. In addition, the granular salt is dissolved during the production to reduce the particle size, or the content of the salt having the particle size decreases, so that the average particle size and the content in the composition obtained after the production are reduced. It is preferable to use a granular salt having a compounding amount larger than a desired amount in the composition in advance so as to be in the above range.

【0010】本発明の口腔用組成物には、更に平均粒径
30〜500μm、特に好ましくは80〜250μmの重曹を配合す
ることができ、当該粒子によりマッサージ感をより高め
ることができる。このような重曹は、全組成中に5〜30
重量%配合するのが好ましく、特に10〜20重量%配合す
ると、マッサージ感をより向上させることができるので
好ましい。
The oral composition of the present invention further comprises an average particle size.
Baking soda having a particle size of 30 to 500 µm, particularly preferably 80 to 250 µm, can be blended, and the particles can further enhance the massage feeling. Such baking soda has 5 to 30 parts in the total composition.
% By weight, and more preferably 10 to 20% by weight, because the massage feeling can be further improved.

【0011】本発明の口腔用組成物は、前記の粒状食塩
以外の形態の食塩、例えば前記以外の粒径の粒状食塩、
溶液状食塩等を任意の割合で含有することができる。食
塩全体の含有量は、本発明組成物中に15重量%以上であ
ることが好ましく、その上限については特に制限はない
が、口腔用組成物としての実用的な形状や形態を考慮す
ると、約40重量%程度が好ましい。
The composition for oral cavity of the present invention comprises a salt in a form other than the above-mentioned granular salt, for example, a granular salt having a particle size other than the above,
A solution salt or the like can be contained at an arbitrary ratio. The content of the entire salt is preferably 15% by weight or more in the composition of the present invention, and the upper limit is not particularly limited. However, considering the practical shape and form of the composition for oral cavity, it is about About 40% by weight is preferred.

【0012】本発明の口腔用組成物は、常法により製造
することができ、通常口腔用組成物として用いられてい
る剤型、例えば練歯磨、粉歯磨、歯肉局所塗布剤等とす
ることができる。
The oral composition of the present invention can be produced by a conventional method, and can be made into a dosage form usually used as an oral composition, for example, toothpaste, powdered toothpaste, topical gingival preparation and the like. it can.

【0013】本発明の口腔用組成物にはその形態等に応
じて種々の公知成分を用いることができる。例えばグリ
セリン、ソルビット、プロピレングリコール、1,3−
ブチレングリコール、エチレングリコール、ポリエチレ
ングリコール、ポリプロピレングリコール、キシリッ
ト、マルチット、ラクチット等の湿潤剤;カルボキシメ
チルセルロース及びその塩類、メチルセルロース、ヒド
ロキシエチルセルロース、カラギーナン、ポリアクリル
酸ナトリウム、ヒドロキシプロピルセルロース、カルボ
キシメチルヒドロキシエチルセルロースナトリウム、ア
ルギン酸ナトリウム、アルギン酸プロピレングリコール
エステル、キサンタンガム、トラガカントガム、カラヤ
ガム、アラビヤガム、ポリビニルアルコール、ポリビニ
ルピロリドン、ビーガム、ラポナイト等の粘結剤;モノ
フルオルリン酸ナトリウム、フッ化スズ、フッ化ナトリ
ウム等の歯質強化剤;クロルヘキシジンの塩類、塩化セ
チルピリジニウム等の殺菌剤;リン酸ナトリウム等のpH
調整剤;デキストラナーゼ、アミラーゼ、プロテアー
ゼ、リゾチーム、ムタナーゼ等の酵素類;ヒノキチオー
ル、ε−アミノカプロン酸、トラネキサム酸、アラント
イン類、トコフェロール類、ジヒドロコレステロール、
グリチルレチン酸、グリチルリチン酸及びその塩類、グ
リセロホスフェート、クロロフィル、水溶性無機リン酸
化合物、アズレン、カミツレ、当帰、川弓、生薬類等の
抗炎症剤・血行促進剤;ラウリル硫酸塩、ミリスチル硫
酸塩、α−オレフィンスルホン酸塩、N−アシルアミノ
酸塩、アシルモノグリセリド硫酸塩、石鹸、脂肪酸モノ
グリセリド、脂肪酸モノアルカノールアミド、ポリオキ
シエチレンソルビタン脂肪酸エステル、ポリオキシエチ
レン硬化ヒマシ油、アルキルグリコシド、イミダゾリニ
ウムベタイン、アルキルベタイン、アルキルアミドベタ
イン、スルホベタイン、アミンオキサイド等の界面活性
剤;サッカリンナトリウム、ステビオサイド、タウマチ
ン、アスパラチルフェニルアラニンメチルエステル等の
甘味剤;p−ヒドロキシ−安息香酸、p−ヒドロキシ−
安息香酸エチル、p−ヒドロキシ−安息香酸プロピル、
p−ヒドロキシ−安息香酸ブチル、安息香酸ナトリウム
等の防腐剤;二酸化チタン等の着色剤・色素類;ペパー
ミント油、スペアミント油、メントール、カルボン、ア
ネトール、オイゲノール、サリチル酸メチル、リモネ
ン、オシメン、n−デシルアルコール、シトロネロー
ル、α−テルピネオール、メチルアセテート、シトロネ
リルアセテート、メチルオイゲノール、シネオール、リ
ナロール、エチルリナロール、ワニリン、チモール、ア
ニス油、レモン油、オレンジ油、セージ油、ローズマリ
ー油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油、
丁子油、ユーカリ油等の香料などを、本発明の効果を損
わない範囲で適宜使用できる。
Various known components can be used in the oral composition of the present invention depending on the form and the like. For example, glycerin, sorbit, propylene glycol, 1,3-
Wetting agents such as butylene glycol, ethylene glycol, polyethylene glycol, polypropylene glycol, xylitol, maltitol, lactit; carboxymethylcellulose and salts thereof, methylcellulose, hydroxyethylcellulose, carrageenan, sodium polyacrylate, hydroxypropylcellulose, sodium carboxymethylhydroxyethylcellulose, Binders such as sodium alginate, propylene glycol alginate, xanthan gum, gum tragacanth, gum karaya, gum arabic, polyvinyl alcohol, polyvinylpyrrolidone, veegum, laponite; tooth toughening such as sodium monofluorophosphate, tin fluoride, sodium fluoride Agents: Chlorhexidine salts, cetylpyridinium chloride, etc. pH such as sodium phosphate; fungicides
Regulators; enzymes such as dextranase, amylase, protease, lysozyme, and mutanase; hinokitiol, ε-aminocaproic acid, tranexamic acid, allantoins, tocopherols, dihydrocholesterol,
Glycyrrhetinic acid, glycyrrhizic acid and its salts, glycerophosphate, chlorophyll, water-soluble inorganic phosphate compounds, azulene, chamomile, Toki, Kawaumi, herbal medicines and other anti-inflammatory agents and blood circulation promoters; lauryl sulfate, myristyl sulfate , Α-olefin sulfonate, N-acyl amino acid salt, acyl monoglyceride sulfate, soap, fatty acid monoglyceride, fatty acid monoalkanolamide, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, alkyl glycoside, imidazolinium betaine Surfactants such as sodium, alkylbetaine, alkylamidobetaine, sulfobetaine, and amine oxide; sweeteners such as saccharin sodium, stevioside, thaumatin, and asparatylphenylalanine methyl ester; Carboxy - benzoic acid, p- hydroxy -
Ethyl benzoate, p-hydroxy-propyl benzoate,
Preservatives such as p-hydroxy-butyl benzoate and sodium benzoate; coloring agents and pigments such as titanium dioxide; peppermint oil, spearmint oil, menthol, carvone, anethole, eugenol, methyl salicylate, limonene, ocimene, n-decyl Alcohol, citronellol, α-terpineol, methyl acetate, citronellyl acetate, methyl eugenol, cineole, linalool, ethyl linalool, crocodile, thymol, anise oil, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil , Laurel oil, perilla oil, winter green oil,
Flavors such as clove oil, eucalyptus oil and the like can be appropriately used as long as the effects of the present invention are not impaired.

【0014】[0014]

【発明の効果】本発明の口腔用組成物は、優れたマッサ
ージ効果により血流量を高めることができ、歯周疾患の
予防・治療効果に優れたものである。また、従来の口腔
用組成物に用いられる粒状食塩よりも更に粒径の大きな
食塩を配合しているため、塩辛さも低減されて味が良
く、更に、粒径が大きく表面積が小さいため、溶けにく
く、マッサージ感が持続する。
EFFECT OF THE INVENTION The oral composition of the present invention can enhance blood flow by an excellent massage effect, and is excellent in prevention and treatment of periodontal disease. In addition, since salt having a larger particle size is blended than the granular salt used in the conventional oral composition, the saltiness is reduced and the taste is good, and since the particle size is large and the surface area is small, it is difficult to dissolve. , The feeling of massage lasts.

【0015】[0015]

【実施例】次に実施例を挙げて本発明を更に説明する
が、本発明はこれによって何ら限定されるものではな
い。なお、粒状食塩の平均粒径の測定は、JIS Z8
801−1994試験用標準ふるいにより行った。
EXAMPLES The present invention will be further described with reference to the following examples, but the present invention is not limited thereto. The average particle size of the granular salt is measured according to JIS Z8.
The test was carried out using a standard sieve for 801-1994 test.

【0016】実施例1 表1に示す組成の成分を用い、練歯磨組成物を常法によ
り製造し、これらを使用したときの血流促進効果を評価
した。結果を図1に示す。なお、得られた組成物中にお
ける粒状食塩の含有量は3〜15重量%の範囲内であっ
た。
Example 1 Toothpaste compositions were prepared by a conventional method using the components having the compositions shown in Table 1, and the effect of promoting blood flow when these compositions were used was evaluated. The results are shown in FIG. In addition, the content of the granular salt in the obtained composition was in the range of 3 to 15% by weight.

【0017】[0017]

【表1】 [Table 1]

【0018】(評価方法)歯肉に炎症を有する男性6名
を被験者とし、上顎3〜3歯について、ラウンドカット
歯ブラシ(8/1000)及び練歯磨1gを用いてブラ
ッシングしたときの血流量を測定した。測定は、被験者
を仰向けに寝かせアングルワイダーをしたまま術者磨き
で1分間ブラッシングした後、5分ごとにレーザードッ
プラー法による血流測定を行った。結果はブラッシング
前との相対血流量とし、6名の平均値で示した。
(Evaluation method) Six males with gingival inflammation were taken as subjects, and blood flow was measured for 3 to 3 maxillary teeth when brushing with a round-cut toothbrush (8/1000) and 1 g of toothpaste. . For the measurement, the subject was laid on his / her back, brushed for 1 minute with the surgeon's polish while holding the angle weider, and then the blood flow was measured by the laser Doppler method every 5 minutes. The results were the relative blood flow before brushing, and were shown as the average value of 6 subjects.

【0019】図1の結果から明らかなように、平均粒径
1000μmの粒状食塩を含有する本発明品を用いた場合に
は、平均粒径350μmの粒状食塩を含有する比較品に比
べ、血流量がより高められていた。
As is apparent from the results shown in FIG.
When the product of the present invention containing 1000 μm of granular salt was used, the blood flow rate was higher than that of the comparative product containing granular salt of 350 μm in average particle size.

【0020】実施例2 次に示す組成の成分を用い、口腔用組成物を常法により
製造した。得られた組成物中において、粒状食塩(平均
粒径1000μm)の含有量は3〜15重量%の範囲内であっ
た。得られた組成物は、マッサージ効果及び味の点で優
れていた。
Example 2 An oral composition was prepared by a conventional method using the following components. In the obtained composition, the content of granular salt (average particle size: 1000 μm) was in the range of 3 to 15% by weight. The resulting composition was excellent in terms of massage effect and taste.

【0021】[0021]

【表2】 (成分) (重量%) 粒状食塩(平均粒径1000μm ) 16.00 ソルビトール 14.00 精製グリセリン 7.00 カラギーナン 0.60 カルボキシメチルセルロース 0.60 シリカ 2.01 サッカリンナトリウム 0.03 水酸化アルミニウム 38.70 アルキル硫酸ナトリウム 2.00 香料 0.80 水酸化ナトリウム(48%) 0.21精製水 バランス 100.00(Components) (% by weight) Granular salt (average particle size: 1000 μm) 16.00 Sorbitol 14.00 Purified glycerin 7.00 Carrageenan 0.60 Carboxymethylcellulose 0.60 Silica 2.01 Saccharin sodium 0.03 Hydroxide Aluminum 38.70 Sodium alkyl sulfate 2.00 Fragrance 0.80 Sodium hydroxide (48%) 0.21 Purified water Balance 100.00

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例1において、練歯磨組成物を用いてブラ
ッシングしたときの血流量の変化を示す図である。
FIG. 1 is a graph showing changes in blood flow when brushing is performed using a toothpaste composition in Example 1.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 組成物中において、平均粒径が700〜140
0μmの粒状食塩を3〜15重量%含有する口腔用組成
物。
1. The composition has an average particle size of 700 to 140.
An oral composition containing 3 to 15% by weight of 0 μm granular salt.
JP31204996A 1996-11-22 1996-11-22 Oral composition Expired - Lifetime JP3667472B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP31204996A JP3667472B2 (en) 1996-11-22 1996-11-22 Oral composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31204996A JP3667472B2 (en) 1996-11-22 1996-11-22 Oral composition

Publications (2)

Publication Number Publication Date
JPH10152424A true JPH10152424A (en) 1998-06-09
JP3667472B2 JP3667472B2 (en) 2005-07-06

Family

ID=18024613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31204996A Expired - Lifetime JP3667472B2 (en) 1996-11-22 1996-11-22 Oral composition

Country Status (1)

Country Link
JP (1) JP3667472B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007070256A (en) * 2005-09-05 2007-03-22 Kao Corp Dentifrice composition
JP2008013528A (en) * 2006-07-10 2008-01-24 Kao Corp Dentifrice composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11304888B2 (en) 2019-04-29 2022-04-19 Sunstar Americas, Inc. Oral care composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007070256A (en) * 2005-09-05 2007-03-22 Kao Corp Dentifrice composition
JP4719537B2 (en) * 2005-09-05 2011-07-06 花王株式会社 Toothpaste composition
JP2008013528A (en) * 2006-07-10 2008-01-24 Kao Corp Dentifrice composition

Also Published As

Publication number Publication date
JP3667472B2 (en) 2005-07-06

Similar Documents

Publication Publication Date Title
RU2622022C2 (en) Systems of surfactants for zinc-containing compositions
US20070098650A1 (en) Dental formulation
RU2491928C1 (en) Artificial saliva containing amino acid and using basic amino acid for treating dry mouth
TW200909001A (en) Oral care compositions containing a mixed tocopherol component
US7087219B2 (en) Toothpaste containing anticancer agents
TW200927184A (en) Dentifrice composition containing silicone oil beads
JPH1112142A (en) Oral composition
JP2002179541A (en) Composition for oral cavity containing cationic disinfectant
JPH04501863A (en) Oral rinse and plaque removal method
JP4147412B2 (en) Oral composition
JP5196997B2 (en) Oral composition
JP3706614B2 (en) Oral composition for suppressing bad breath
JP3241922B2 (en) Oral composition
CA2754213C (en) Desensitizing dentifrice exhibiting dental tissue antibacterial agent uptake
JP3667472B2 (en) Oral composition
JP2964182B2 (en) Dentin hypersensitivity treatment
CA2481004A1 (en) Novel anti-bacterial compositions
JPH11130648A (en) Composition for oral cavity
JPH05331031A (en) Composition for oral cavity
JPH06239723A (en) Composition for oral cavity
JP3511727B2 (en) Oral composition
JPH09132517A (en) Composition for oral cavity
KR900006826B1 (en) Tooth paste composition
JP3241923B2 (en) Oral composition
JPH0338516A (en) Composition for oral cavity

Legal Events

Date Code Title Description
A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20050406

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090415

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090415

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100415

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110415

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120415

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130415

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130415

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140415

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term